HSCS

HeartSciences Inc.
CAPPED RATING

HeartSciences Inc. (HSCS) is rated C- (2.1/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (A-); its weakest is Value (F).

Quantitative Factor Evaluation • Updated

Overall Rating
2.1 / 5.0
C-
Value
F
Factor Score 0.0 / 5.0
Growth
C+
Factor Score 2.6 / 5.0
Profitability
D
Factor Score 1.3 / 5.0
Momentum
A-
Factor Score 4.0 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -1.3
EV / EBITDA -1.6
Rev Growth YoY 10.5%
Gross Margin 60.9%
Price Return 3M 11.4%
Price Return 12M -18.0%
Catalyst Signal 0.00
Market Cap $11.4M
TTM Revenue $4.5K
Price / Sales 2.5K
ROE N/M

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-12 F (0.0) C+ (2.6) D (1.3) A- (4.0) C+ (2.6) C- (2.1)
2026-11-05 F (0.0) C+ (2.6) D (1.3) A (4.4) C+ (2.7) C (2.2)
2026-10-29 F (0.0) C+ (2.5) D (1.3) A (4.4) C+ (2.7) C (2.2)
2026-10-22 F (0.0) C+ (2.5) D (1.3) A (4.4) C+ (2.6) C (2.2)
2026-10-15 F (0.0) C+ (2.5) D (1.3) B+ (3.7) C+ (2.6) C- (2.0)
Page 1 of 4